Back
Arrowhead Pharmaceuticals, Inc. 10K Form
Buy
54
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$64.69
Seasonality Move:
40.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ARWR News And Ratings
See the #1 stock for the next 7 days that we like better than ARWR
ARWR Financial Statistics
Sales & Book Value
| Annual Sales: | $829.4M |
|---|---|
| Cash Flow: | $13M |
| Price / Cash Flow: | 55.38 |
| Annual Sales: | $3.43 |
| Price / Book: | 18.96 |
Profitability
| EPS (TTM): | -0.06720 |
|---|---|
| Net Income (TTM): | $30.1M |
| Gross Margin: | $805.5M |
| Return on Equity: | 7.7% |
| Return on Assets: | 2.3% |
Arrowhead Pharmaceuticals, Inc. Earnings Forecast
Key Arrowhead Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 29 years for ARWR is 97.12%.
-
The Selling, General & Administrative Expenses for ARWR have been equal to 14.94% of Gross Profit Margin.
-
The Research & Development expenses have been 70.56% of Revenue.
-
The Interest Expense is 296.74% of Operating Income.
-
The Net Earning history of ARWR is 3.63% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 13 years.
Arrowhead Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ARWR |
| CUSIP: | 04280A |
| Website: | arrowheadpharma.com |
Debt
| Debt-to-Equity Ratio: | 1.57 |
|---|---|
| Current Ratio: | 4.86 |
| Quick Ratio: | 4.74 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ARWR Technical Analysis vs Fundamental Analysis
Buy
54
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Buy
Is Arrowhead Pharmaceuticals, Inc. a Buy or a Sell?
-
Arrowhead Pharmaceuticals, Inc. stock is rated a BuyThe current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $65.08. The Score for ARWR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.